Estrogen-related and other disease diagnoses preceding Parkinson's disease

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 153-170

  Latourelle, Jeanne C ^a,b   Dybdahl, Merete ^c   Destefano, Anita L ^a,b   Myers, Richard H ^a   Lash, Timothy L ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Empirical bayes; Endometriosis; Estrogen; Osteoporosis; Parkinson's disease

Indexed keywords

ESTROGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BAYES THEOREM; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EXPOSURE; ENDOMETRIOSIS; FEMALE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; OSTEOPOROSIS; PARKINSON DISEASE; REGISTER; RISK ASSESSMENT;

EID: 77955501754     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/clep.s9621     Document Type: Article

References (52)

1. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999;52(6):1214-1220.
2. Nicoletti A, Arabia G, Pugliese P, et al. Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial. Clin Neuropharmacol. 2007;30(5):276-280.
3. Blanchet PJ, Fang J, Hyland K, Arnold LA, Mouradian MM, Chase TN. Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study. Neurology. 1999;53(1):91-95.
4. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology. 1999;52(7):1417-1421.
5. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Postmenopausal estrogen use affects risk for Parkinson disease. Archives of Neurology. 2004;61(6):886-888.
6. Ragonese P, D'Amelio M, Salemi G, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology. 2004;62(11):2010-2014.
7. Benedetti MD, Maraganore DM, Bower JH, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord. 2001;16(5):830-837.
8. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology. 2005;65(3):383-390.
9. Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology. 2003;60(5):790-795.
10. Simon KC, Chen H, Gao X, Schwarzschild MA, Ascherio A. Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov Disord. 2009;24(9):1359-1365.
11. Bertelsen L, Mellemkjaer L, Frederiksen K, et al. Risk for breast cancer among women with endometriosis. Inter J Cancer. 2007; 120(6):1372-1375.
12. Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids. 2000; 65(10-11):659-664.
13. Elbaz A, Peterson BJ, Yang P, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology. 2002; 13(2):157-164.
14. Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L, Moller H. Atypical cancer pattern in patients with Parkinson's disease. Brit J Cancer. 2005;92(1):201-205.
15. Inzelberg R, Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology. 2007;69(15):1542-1550.
16. Doshay LJ. Problem situations in the treatment of paralysis agitans. J Am Med Assoc. 1954;156(7):680-684.
17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.
18. Jansson B, Jankovic J. Low cancer rates among patients with Parkinson's disease. Annals of Neurology. 1985;17(5):505-509.
19. Minami Y, Yamamoto R, Nishikouri M, Fukao A, Hisamichi S. Mortality and cancer incidence in patients with Parkinson's disease. J Neurol. 2000;247(6):429-434.
20. Moller H, Mellemkjaer L, McLaughlin JK, Olsen JH. Occurrence of different cancers in patients with Parkinson's disease. BMJ. 1995;310(6993):1500-1501.
21. Khan A. Premenopausal women and low bone density. Canadian Family Physician Medecin de Famille Canadien. 2006;52:743-747.
22. Vaserman N. Parkinson's disease and osteoporosis. Joint Bone Spine. 2005;72(6):484-488.
23. Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR. The association of Parkinson's disease with bone mineral density and fracture in older women. Osteoporos Int. 2008;19(7):1093-1097.
24. Waugh EJ, Lam MA, Hawker GA, et al. Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int. 2009;20(1):1-21.
25. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315(7112):841-846.
26. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002;52(3):276-284.
27. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009; 373(9680):2055-2066.
28. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
29. Maher NE, Golbe LI, Lazzarini AM, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology. 2002;58(1):79-84.
30. Melton LJ 3rd, Thamer M, Ray NF, et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Mineral Res. 1997;12(1):16-23.
31. Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005;16(2):134-141.
32. Steenland K, Bray I, Greenland S, Boffetta P. Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomarkers Prev. 2000;9(9):895-903.
33. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268-279.
34. Baird DT, Fraser IS. Blood production and ovarian secretion rates of estradiol-17 beta and estrone in women throughout the menstrual cycle. J Clin Endocrinol Metab. 1974;38(6):1009-1017.
35. Flood C, Pratt JH, Longcope C. The metabolic clearance and blood production rates of estriol in normal, non-pregnant women. J Clin Endocrinol Metab. 1976;42(1):1-8.
36. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med. 2002;346(5):340-352.
37. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90 Suppl 5:S260-S269.
38. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol. 1989;12(2):98-105.
39. Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry. 2006;77(4):468-473.
40. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368-376.
41. Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand. 2006; 113(4):211-220.
42. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord. 2000;15(4):669-677.
43. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Archives of Neurology. 2003;60(4):521-528.
44. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology. 2000;55(9):1350-1358.
45. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord. 1992;7(4):339-344.
46. Brighina L, Schneider NK, Lesnick TG, et al. Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord. 2009;15(6):430-434.
47. Hernan MA, Logroscino G, Rodriguez LA. A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol. 2004;251 Suppl 7:14-17.
48. Reichman ME, Judd JT, Longcope C, et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Nat Cancer Inst. 1993;85(9):722-727.
49. Purohit V. Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res. 1998;22(5):994-997.
50. Ginsburg ES, Walsh BW, Gao X, Gleason RE, Feltmate C, Barbieri RL. The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol. J Soc Gynecol Investig. 1995;2(1):26-29.
51. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001;286(17):2143-2151.
52. Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol. 2007;150(8):963-976.